Here’s why I’d forget about the Fevertree Drinks share price ‘fad’

Fevertree Drinks (LON: FEVR) has had a poorer 2019 than it expected, but could 2020 be even worse?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In my early investing days, I learned a lot from a Motley Fool colleague who had the knack of identifying what he called ‘fad’ stocks. They’re stocks that capture the mood of the moment, a passing fashion… but typically boom and then bust.

Perhaps they’re selling a new product that’s doing the rounds among young people. Or maybe a company is just making a big deal out of nothing special and advertising it big.

A what specialist?

Today, I’m examining Fevertree Drinks (LSE: FEVR), whose share price boomed in 2018. When I first saw Fevertree described as a tonic water specialist, my fad alert started sounding loudly in my head.

We’ve had all kinds of booze fads in recent years. Does anyone remember alcopops? Or beer with lemon stuck in the neck of the bottle? Or ready-made cocktails? Whenever I look at the supermarket booze section these days, I see more flavoured gins than just about anything else. But that’s a fad, and it will pass.

Now, Fevertree makes more than just fancy tonic waters, it does all sorts of mixers too. But tonic waters do seem to dominate. A quick check on the firm’s products reveals Elderflower tonic water, Aromatic tonic water, Clementine & Cinnamon tonic water… and many more.

I suspect there probably is a longer-term market for fancy mixer drinks, but not as big as hopeful growth investors think. It’s a market that’s very easy to get into too, and I don’t really see how Fevertree has any kind of protective moat or competitive advantage.

Competition

In my search for Fevertree products, I found ‘botanical brewery’ Fentimans offering Botanical, Pink Grapefruit, Mediterranean Orange, and even Connoisseur tonic waters. Then I found Double Dutch brand Cucumber and Watermelon tonic water.

The big names, like Coca-Cola and Schweppes are getting in on the act too — fancy some Russchian Aromatic Citrus tonic water? And then the big supermarkets, like Tesco, are offering their own brands.

I reckon the young people buying all this stuff in the bars probably won’t even know who makes their mixers. Just as long as they can be seen drinking their fashionable, I don’t know, South Seas Tulip tonic water or whatever, I can’t see them caring. People will just buy whatever the bar happens to stock. Until the ‘fancy mixers’ fad is over.

Shares?

So that’s my take on the products — probably decent enough, but probably set to go the way of all those previous drinking fads. But what about Fevertree Drinks shares?

The share price is way down from its peak, suffering an extra crunch when the firm’s latest year-end trading update was released. On 20 January, Fevertree shares lost more than a quarter of their value in just the one day. The update confirmed all my worst fears about rising competition.

Even after that dip, we’re still looking at a forward P/E of probably about 28 — around twice the FTSE 100‘s long-term average. I think Fevertree is still an overpriced fad stock.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

Should I buy these UK shares for my portfolio?

This Fool has been searching for ways to capitalise on the commodity moves via UK shares. Here’s what he’s watching.

Read more »

Illustration of flames over a black background
Investing Articles

Just released: April’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

£9,000 in savings? Here’s a FTSE 100 stock I’d buy to target a £30,652 annual second income!

Our writer highlights one top FTSE 100 share that he thinks could help create a portfolio large enough for a…

Read more »

Light bulb with growing tree.
Investing Articles

62% down! Is the Ceres Power share price now a green energy bargain?

Annual results from the green energy firm showed a company on the cusp of doubling sales. So why has the…

Read more »

Investing Articles

3 mid-cap UK defence shares to consider buying in 2024

Defence budgets are soaring as global conflicts increase the threat landscape, so I'm examining the value proposition of three defence-related…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Hargreaves Lansdown investors have been buying dividend stocks BP and Shell. Should I?

Cherished dividend stocks BP and Shell have outperformed the FTSE 100 index so far in 2024. Paul Summers takes a…

Read more »

Young Asian man shopping in a supermarket
Dividend Shares

A 5% yield? Here’s the 3-year dividend forecast for Tesco shares

Jon Smith flags up the positive momentum for Tesco shares following the release of the full-year results and looks at…

Read more »

Investing Articles

Yields up to 12.3% 3 top shares investors should consider for a second income

Searching for ways to make a market-beating second income? These popular dividend stocks are worth serious consideration, says Royston Wild.

Read more »